The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 19, 2019

Filed:

Nov. 02, 2016
Applicant:

University of Virginia Patent Foundation, Charlottesville, VA (US);

Inventors:

Kyle Hoehn, Charlottesville, VA (US);

Brandon Kenwood, Atlanta, GA (US);

Assignee:

UNIVERSITY OF VIRGINIA PATENT FOUNDATION, Charlottesville, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/04 (2006.01); G01N 33/50 (2006.01); A61K 31/4985 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07D 498/04 (2013.01); A61K 9/0053 (2013.01); A61K 31/4985 (2013.01); G01N 33/5014 (2013.01); G01N 33/5079 (2013.01); G01N 2500/10 (2013.01);
Abstract

The present invention encompasses the use of compounds for a novel approach to treat and prevent diseases, conditions, and disorders such as diabetes and ischemic reperfusion injury. Compounds of the invention, including but not limited to BAM15 ((2-fluorophenyl){6-[(2-fluorophenyl)amino](1,2,5-oxadiazolo[3,4-e]pyrazin-5-yl)}amine), a mitochondrial uncoupler, can improve glucose tolerance, increases cellular oxygen consumption, treat or prevent kidney ischemia reperfusion injury reverse insulin resistance, reverse or treat hyperinsulinemia, and reverse or treat hyperlipidemia. The present invention further provides novel compounds as well as methods for identifying compounds with the same or similar properties as BAM15.


Find Patent Forward Citations

Loading…